Natallia Rameika
Uppsala, C, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
A human pan-disease blood atlas of the circulating proteome.
Journal: Science (New York, N.Y.)
Published: October 09, 2025
NAT2 activity increases cytotoxicity of anthracycline antibiotics and HDAC inhibitors.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: December 08, 2024
Identification of a small molecule targeting EPLIN as a novel strategy for the treatment of pediatric neuroblastoma and medulloblastoma.
Journal: Cell death & disease
Published: September 23, 2024
Next generation pan-cancer blood proteome profiling using proximity extension assay.
Journal: Nature communications
Published: October 26, 2022
Enhanced cytotoxicity of a novel family of ATPase inhibitors in colorectal cancer cells with high NAT2 activity.
Journal: Biochemical pharmacology
Published: May 24, 2022
Defining eligible patients for allele-selective chemotherapies targeting NAT2 in colorectal cancer.
Journal: Scientific reports
Published: April 03, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026